Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Non-cash Items (2023 - 2025)

Nuvation Bio (NUVB) has disclosed Non-cash Items for 3 consecutive years, with $1.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-cash Items rose 158.58% to $1.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.9 million, a 158.58% increase, with the full-year FY2025 number at $1.9 million, up 158.58% from a year prior.
  • Non-cash Items was $1.9 million for Q4 2025 at Nuvation Bio, down from $32.3 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $32.3 million in Q3 2025 to a low of $748375.0 in Q4 2024.
  • A 3-year average of $15.3 million and a median of $11.9 million in 2024 define the central range for Non-cash Items.
  • Peak YoY movement for Non-cash Items: soared 287.88% in 2024, then increased 23.6% in 2025.
  • Nuvation Bio's Non-cash Items stood at $8.5 million in 2023, then crashed by 91.22% to $748375.0 in 2024, then surged by 158.58% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for NUVB's Non-cash Items are $1.9 million (Q4 2025), $32.3 million (Q3 2025), and $29.6 million (Q2 2025).